Question 1

What is Bicara Therapeutics Inc. (BCAX)'s latest operating cash flow?

Accepted Answer

Bicara Therapeutics Inc. (BCAX)'s operating cash flow for FY2025 was -$106.8M, as reported in its SEC filings.

Question 2

How has Bicara Therapeutics Inc. (BCAX)'s operating cash flow changed year over year?

Accepted Answer

BCAX's operating cash flow went from -$74.8M in FY2024 to -$106.8M in FY2025, a decrease of 42.9%.

Question 3

What is the highest operating cash flow Bicara Therapeutics Inc. (BCAX) reported over FY2023–FY2025?

Accepted Answer

The highest reported operating cash flow over FY2023–FY2025 was -$45.6M, in FY2023.

Question 4

What years does this operating cash flow history cover?

Accepted Answer

This page shows BCAX's operating cash flow for each fiscal year from FY2023 to FY2025, drawn from SEC XBRL filings.

Bicara Therapeutics Inc. (BCAX) Operating cash flow 2023–2025

More BCAX financial trends